In addition, we found that DFS and OS significantly associated with clinical stage, tumor size, regional LN metastasis, adjuvant treatment, CEA, and Cyfra21-1 in the EGFR wild-type adenocarcinoma patients (Table 3). The gene discussed is EGFR; the disease is adenocarcinoma.